Tenon Medical, Inc.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $TNON in the last 30 days.
See all $TNON insider activity →Tenon Medical (TNON) secured waivers from an institutional investor and WallachBeth Capital to increase shares in its at-the-market offering. In exchange, TNON issued a warrant for 125,000 shares at $5.02, expiring in 2031, and agreed to register shares for resale. The waivers support the planned offering increase, with certain restrictions extended by 15 days.
Tenon Medical, Inc. (TNON) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. As previously disclosed, on August 27, 2026, Tenon Medical, Inc., a Delaware corporation (the “Company”), entered into a securities purchase agreement (the “Purchase Agreement”) with a certain institutional investor (the “Inve
Tenon Medical (TNON) launched its SImmetry+ SI Joint Fusion System after a successful alpha phase that generated $1.2M in revenue. The company plans to expand inventory to meet demand and expects more product launches. Physicians reported positive feedback on the system's design and effectiveness.
Over the past 7 days, AlphAI's AI scored 2 news stories mentioning TNON (Tenon Medical, Inc.). Coverage has skewed bearish: 0 bullish, 0 neutral, and 2 bearish.
Recent TNON coverage spans corporate actions, insider activity and technology.
The warrant and increased share pool could dilute existing shareholders and add supply pressure.
Potential dilution and increased share supply could pressure the stock price.
The launch adds a new revenue stream but the disclosed amount is modest.
The launch adds a new revenue stream and may modestly boost the stock as investors price in future growth.
The capital raise provides near‑term cash but dilutes existing shareholders; short‑term price impact likely modest.
AlphAI scores every news story that mentions TNON with an AI model for sentiment and relevance, and aggregates insider trades from Tenon Medical, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Tenon Medical (TNON) secured waivers from an institutional investor and WallachBeth Capital to increase shares in its at-the-market offering. In exchange, TNON issued a warrant for 125,000 shares at $5.02, expiring in 2031, and agreed to register shares for resale. The waivers support the planned offering increase, with certain restrictions extended by 15 days.
1 min readTenon Medical, Inc. (TNON) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. As previously disclosed, on August 27, 2026, Tenon Medical, Inc., a Delaware corporation (the “Company”), entered into a securities purchase agreement (the “Purchase Agreement”) with a certain institutional investor (the “Inve
1 min readTenon Medical (TNON) launched its SImmetry+ SI Joint Fusion System after a successful alpha phase that generated $1.2M in revenue. The company plans to expand inventory to meet demand and expects more product launches. Physicians reported positive feedback on the system's design and effectiveness.
2 min readTenon Medical (NASDAQ:TNON) launched its SImmetry+ SI Joint Fusion System, generating $1.2M in revenue during its alpha phase. The company plans to expand inventory to meet demand and expects more product launches. The system received positive physician feedback and aims to address a broader range of patient anatomies. Tenon believes this platform will drive growth and solidify its market position.
2 min readTenon Medical, Inc. (TNON) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Exhibit 99.1 Tenon Medical Announces Warrant Inducement for Aggregate Gross Proceeds of Approximately $2,872,338 LOS GATOS, CA / ACCESS Newswire / September 11, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) (“Tenon” or the “Company”), a medical device company dedicated to transforming
1 min readTenon Medical (TNON) closed a warrant inducement offering, raising $2,872,338.58. The company issued new warrants for 858,269 shares at $5.02 per share, exercisable immediately. The funds will be used for general corporate purposes, excluding fees and expenses.
1 min readTenon Medical (TNON) announced a warrant inducement deal with an institutional investor, exercising existing warrants for $2.87M in gross proceeds. The company will issue new warrants for 858,269 shares at $5.02 per share, exercisable immediately. The transaction is expected to close on September 14, 2026, subject to customary conditions.
1 min readHRT FINANCIAL LP sold 125,925 shares of Tenon Medical, Inc. (TNON) at an average of $4.28 ($2.61–$5.56, $0.54M total) across 3 trades over 2026-09-09 to 2026-09-10.
1 min readHRT FINANCIAL LP purchased 108,140 shares of Tenon Medical, Inc. (TNON) at an average of $3.54 ($2.92–$4.92, $0.38M total) across 5 trades over 2026-09-08 to 2026-09-10.
1 min readTenon Medical Inc. (NASDAQ: TNON) shares surged 53.64% after repaying $5.16M in convertible notes, reducing debt risk. The company reported Q2 2026 revenue of $1.3M, up 127% YoY, with a 64% gross margin. Despite strong growth, TNON faces financial challenges, including a $4.05M net loss and negative equity. Traders are monitoring the stock due to its volatility and recent catalysts, such as FDA clearance and increased surgical volume.
3 min read
